Schwab International Equity ETF (SCHF) trades at $27.30, 2.2% below its September 25, 2026 closing peak of $27.92, and the evidence has moved from negative to even. On October 20, 2026 the reading was bearish with medium conviction. The price is now above its 40-week average, which makes this a pullback inside a weekly uptrend. Conviction is low, 0 of 4, because the fund still lags the S&P 500 over 50 days.
Why it matters
No news event explains the recent move. The news set contains no fund-specific headline, no flow report and no holdings change, so this is a drift, not a reaction. SCHF rose 0.6% today and 0.3% over five days, but it is down 1.5% over a month. Today's volume is 34% below its 20-day average, so the bounce comes on thin participation and does not yet show buyers committing.
Against the market, the picture is mixed. Over five days SCHF gained 0.33% while SPY slipped 0.06%, so the basket edged ahead this week. The month is the reverse: SCHF fell 1.5% while SPY rose 0.9%. Year to date the two are almost level, at 13.6% for SCHF and 13.3% for SPY. The longer comparisons still favor the US market, with SCHF behind SPY by 2.1% over 50 days and 4.3% over 200 days. No sector benchmark is available, and the data does not say which holdings or countries drove the recent weakness or the bounce. Any claim about that would be a guess.
The debate around the basket is carried by individual names, not the fund. On September 22, 2026, Morningstar argued that three wide-moat international stocks trade below fair value, including AstraZeneca at $184 per ADR and ASML. That is the constructive case for non-US large caps. On September 29, 2026, Morningstar made a similar pullback-and-rebound argument for Lockheed Martin, with a $650 fair value, and NXP Semiconductors. Neither piece is about SCHF, and no article in the set makes the opposing case. The counter-argument comes from the price itself: the fund has trailed the US market for 50 days and sits below its 10-week average.
An ETF has no analyst target or earnings date, so there is no spread to weigh. The fair values above belong to single stocks. The 52-week range is the only valuation-like anchor: $22.96 to $28.59, with the price 18.9% above the low and 4.5% below the high.
What the evidence says
The long-term thesis is intact but not strong. Price sits above both the 40-week average and the 200-day average at $26.87, and the fund is still near the upper part of its 52-week range. The phase is a pullback after a run toward the high. The earlier report of October 20, 2026 was bearish with medium conviction, when the price was below its 40-week average, so the trend and the call pointed the same way, and it set a weekly close above $27.68 as the level that would change that picture. That reading has changed. With price back above the 40-week average, the downtrend that anchored the bearish case is gone. The fund still lags the US market, so nothing yet supports a positive lean either.
For the next two to six weeks the balance of evidence is even, and the reading is weak, scoring 0 of 4. Two things stand out: a pullback against the weekly uptrend that is not stretched, with RSI at 55, and the 2.1% lag against the S&P 500 over 50 days, which runs against the trend. They offset each other. The strongest case against an even reading is the negative one: the fund is below its 50-day average at $27.71 and its 10-week average, it trails SPY over every window beyond a week, and the bounce comes on light volume. That does not tip the balance, because the price still holds above the 40-week and 200-day averages, so a confirmed downtrend is not in place. It is also the main reason conviction is not higher in either direction.
Levels that matter
The structure holds above $27.29, a swing zone, and a close under it would be the first crack. The trend itself ends below $26.87, the 200-day average, with another swing zone at $26.69 just beneath. Those two levels matter because they mark the last pivot and the long-term average that the weekly uptrend rests on.
The breakout level is a daily close above $27.71, the 50-day average, on volume above its 20-day average. From there the first target is $27.91, a swing zone, and the second is $28.51. Measured against a stop at $27.22, which is the $27.29 swing zone minus a quarter of the 14-day ATR of $0.27, the reward-to-risk is 0.4 to 1 for the first target and 1.6 to 1 for the second. The math does not reach 3 to 1. It would take a target well beyond $28.51, toward the round $30 level, to stretch the reward enough, and no resistance on the map sits between those two prices.
What would change the picture
A weekly close below $26.87, the 200-day average, would break the weekly uptrend and move the reading toward negative. The non-price fact that would do it is evidence that capital is leaving developed-market equities outside the US, such as sustained fund outflows or a clear deterioration in the largest holdings. Nothing in the news provided shows that today. In the other direction, a daily close above $27.71 on above-average volume would be the first sign that buyers are back.
What to watch
- The $27.29 level: a close below it is the first crack in the structure.
- The $27.71 level on volume above the 20-day average, which would put the first target at $27.91.
- The weekly close against $26.87, the 200-day average, the line that separates a pullback from a trend break.
- The gap with SPY: the fund is 2.1% behind over 50 days, and narrowing that lag would remove the main item weighing on the evidence.
- Any fund flow or holdings news. None is in the current data, and no scheduled earnings or policy dates are available for the basket.